1
On April 27, 2010, the USPTO issued U.S. Patent 7,704,507 directed to a method for creating an anti-cancer vaccine. This patent is assigned to the University of Virginia Patent Foundation and the University of Pittsburgh. This method primes T cells against tumor antigens using a culture of antigen presenting cells (APCs) with protein or peptides from cancerous cells, then uses the primed T cells as an antigen identifier or treatment for cancer.


Wow, the original provisional application was filed in 2001. If this vaccine actually works, I really feel for the people who have suffered in some way due to cancer in the last 9 years…